全文获取类型
收费全文 | 14913篇 |
免费 | 1101篇 |
国内免费 | 66篇 |
专业分类
耳鼻咽喉 | 204篇 |
儿科学 | 279篇 |
妇产科学 | 202篇 |
基础医学 | 2236篇 |
口腔科学 | 158篇 |
临床医学 | 1533篇 |
内科学 | 3643篇 |
皮肤病学 | 392篇 |
神经病学 | 1415篇 |
特种医学 | 647篇 |
外国民族医学 | 10篇 |
外科学 | 2327篇 |
综合类 | 41篇 |
一般理论 | 5篇 |
预防医学 | 683篇 |
眼科学 | 198篇 |
药学 | 955篇 |
中国医学 | 14篇 |
肿瘤学 | 1138篇 |
出版年
2024年 | 18篇 |
2023年 | 161篇 |
2022年 | 279篇 |
2021年 | 646篇 |
2020年 | 347篇 |
2019年 | 538篇 |
2018年 | 649篇 |
2017年 | 417篇 |
2016年 | 477篇 |
2015年 | 548篇 |
2014年 | 733篇 |
2013年 | 866篇 |
2012年 | 1312篇 |
2011年 | 1293篇 |
2010年 | 700篇 |
2009年 | 631篇 |
2008年 | 970篇 |
2007年 | 951篇 |
2006年 | 810篇 |
2005年 | 753篇 |
2004年 | 642篇 |
2003年 | 552篇 |
2002年 | 479篇 |
2001年 | 110篇 |
2000年 | 116篇 |
1999年 | 96篇 |
1998年 | 89篇 |
1997年 | 60篇 |
1996年 | 60篇 |
1995年 | 56篇 |
1994年 | 45篇 |
1993年 | 40篇 |
1992年 | 58篇 |
1991年 | 64篇 |
1990年 | 56篇 |
1989年 | 49篇 |
1988年 | 35篇 |
1987年 | 37篇 |
1986年 | 34篇 |
1985年 | 21篇 |
1984年 | 26篇 |
1983年 | 31篇 |
1982年 | 35篇 |
1981年 | 14篇 |
1980年 | 15篇 |
1979年 | 18篇 |
1978年 | 16篇 |
1977年 | 13篇 |
1974年 | 14篇 |
1972年 | 13篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
Raymond J. Chan RN PhD Vivienne E. Milch MBBS MHPol Fiona Crawford-Williams PhD Oluwaseyifunmi Andi Agbejule BRadTherapy Ria Joseph MNutrDiet Jolyn Johal BND Narayanee Dick BSc Matthew P. Wallen PhD Julie Ratcliffe PhD Anupriya Agarwal MBBS Larissa Nekhlyudov MD Matthew Tieu PhD Manaf Al-Momani BPharm Scott Turnbull PhD Rahul Sathiaraj MPH Dorothy Keefe MBBS MD Nicolas H. Hart PhD 《CA: a cancer journal for clinicians》2023,73(6):565-589
Patient navigation is a strategy for overcoming barriers to reduce disparities and to improve access and outcomes. The aim of this umbrella review was to identify, critically appraise, synthesize, and present the best available evidence to inform policy and planning regarding patient navigation across the cancer continuum. Systematic reviews examining navigation in cancer care were identified in the Cochrane Central Register of Controlled Trials (CENTRAL), PubMed, Embase, Cumulative Index of Nursing and Allied Health (CINAHL), Epistemonikos, and Prospective Register of Systematic Reviews (PROSPERO) databases and in the gray literature from January 1, 2012, to April 19, 2022. Data were screened, extracted, and appraised independently by two authors. The JBI Critical Appraisal Checklist for Systematic Review and Research Syntheses was used for quality appraisal. Emerging literature up to May 25, 2022, was also explored to capture primary research published beyond the coverage of included systematic reviews. Of the 2062 unique records identified, 61 systematic reviews were included. Fifty-four reviews were quantitative or mixed-methods reviews, reporting on the effectiveness of cancer patient navigation, including 12 reviews reporting costs or cost-effectiveness outcomes. Seven qualitative reviews explored navigation needs, barriers, and experiences. In addition, 53 primary studies published since 2021 were included. Patient navigation is effective in improving participation in cancer screening and reducing the time from screening to diagnosis and from diagnosis to treatment initiation. Emerging evidence suggests that patient navigation improves quality of life and patient satisfaction with care in the survivorship phase and reduces hospital readmission in the active treatment and survivorship care phases. Palliative care data were extremely limited. Economic evaluations from the United States suggest the potential cost-effectiveness of navigation in screening programs. 相似文献
3.
4.
Matthieu Talagas Nicolas Lebonvallet Franois Berthod Laurent Misery 《Experimental dermatology》2019,28(12):1466-1469
Recent years have brought an enhanced understanding of keratinocyte contribution to cutaneous nociception. While intra‐epidermal nerve endings were classically considered as the exclusive transducers of cutaneous noxious stimuli, it has now been demonstrated that epidermal keratinocytes can initiate nociceptive responses, like Merkel cells do for the innocuous mechanotransduction. In the light of recent in vivo findings, this article outlines this paradigm shift that points to a not yet considered population of sensory epidermal cells. 相似文献
5.
6.
Sundaram Kavin Piuzzi Nicolas S. Patterson Brendan M. Stearns Kim L. Krebs Viktor E. Mont Michael A. 《European journal of orthopaedic surgery & traumatology : orthopedie traumatologie》2020,30(3):447-453
European Journal of Orthopaedic Surgery & Traumatology - The goals of this study were to compare patient satisfaction and wound-related complications in patients receiving 2-octyl cyanoacrylate... 相似文献
7.
8.
9.
10.
Philippe Nickers Luc Coppens Jean de Leval Nicolas Jansen Jean-Marie Deneufbourg 《Radiotherapy and oncology》2006,79(3):329-334
BACKGROUND AND PURPOSE: To evaluate on 201 locally advanced prostatic cancers prospectively treated in a phase II trial, the efficacy of a combination of external beam radiotherapy (39.6 Gy) and (192)Ir low dose rate brachytherapy (Bt) (40-45 Gy). PATIENTS AND METHODS: Sixty-four patients were included in the intermediate prognosis group with only one of the following adverse factors (PSA > 10 ng/ml, Gleason score > or = 7 or clinical stage > or =T2b) and 137 in the unfavourable group when at least two of these factors were present. RESULTS: The actuarial 4 years biochemical no evidence of disease is 82.8% for the entire population. It is, respectively, 97 and 76% in the intermediate and unfavourable prognosis groups (P < 0.0001). Grade > or =3 late urinary complications occurred in 13 patients (6.5%). Eight patients (4%) presented late grade 2 rectal complications but no grades 3-5 was observed. CONCLUSIONS: Even if an alpha/beta of 1.5-3 Gy theoretically favours the use of a high dose rate mode of irradiation, the early results presented here are as good as those reported for similar groups of patients with high dose rate treatments. Late toxicity is identical but our urinary toxicity is within the less favourable and rectal toxicity within the most favourable results. We can postulate that while inducing very high hyperdosage regions (V150) mainly focused on the peripheral zone, most of the Bt techniques consist of a more ablative treatment. Many of the radiobiological studies on Bt did not in fact take into account the heterogeneity of irradiation inside the CTV. This study highlights the need to explore pulsed dose rate therapies, permanent implant and new available radioisotopes such as (169)Ytterbium that will offer the safety of low and lower dose rates. The actual late toxicity of the different Bt techniques is not yet inexistent indeed. 相似文献